4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000092
Options or other derivatives
- President and CEO acquired 105,840 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BLATT LAWRENCE · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-09 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +105,840 | 105,840 | D |
Loading xslF345X05/form4.xml…